Clinical data for Episealer® to be presented at sports medicine congress in the United Kingdom
Episurf Medical (Nasdaq: EPIS B) today announces that its implant technology, and clinical results from the use of the Episealer® implant, will be presented at the sports medicine congress “Sports Knee 2019”. The congress will be arranged at St George’s Park Burton-on-Trent on November 25-26, 2019. The presentation will be held by Associate Professor Tim Spalding, University Hospitals Coventry and Warwickshire NHS Trust. The clinical results come from a European multicenter study with 100 patients in the “gap age”, 35-60 years old, that have undergone treatment of focal chondral defects